KDA Group Inc. (TSXV:KDA)

Revenue by Segment

Financials in millions CAD. Fiscal year is August - July.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020	Jul 31, 2019	Jul 31, 2018	Jul 31, 2017	Jul 31, 2016
Pharmaceutical Technology	96.00K	37.00K	95.00K	207.00K	-
Pharmaceutical Technology Growth	159.46%	-61.05%	-54.11%	-	-
Corporate and Others	69.00K	110.00K	66.00K	-	69.00K
Corporate and Others Growth	-37.27%	66.67%	-	-	16.62%
Pharmaceutical Solutions	-	-	-	-	11.14M
Pharmaceutical Solutions Growth	-	-	-	-	11.72%
Pharmacy Services	-	-	-	-	13.17M
Pharmacy Services Growth	-	-	-	-	2.32%
Total	165.00K	147.00K	161.00K	207.00K	24.37M
Total Growth	12.24%	-8.70%	-22.22%	-99.15%	6.45%

Revenue by Geography

Financials in millions CAD. Fiscal year is August - July.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020	Jul 31, 2019	Jul 31, 2018	Jul 31, 2017	Jul 31, 2016
Canada	165.40K	147.42K	161.12K	207.09K	24.37M
Canada Growth	12.20%	-8.51%	-22.20%	-99.15%	6.45%
Total	165.40K	147.42K	161.12K	207.09K	24.37M
Total Growth	12.20%	-8.51%	-22.20%	-99.15%	6.45%

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 21, 2026

Data Sources Report a data error